This inventor holds 4 USPTO granted patents and 3 published patent applications and 1 EPO patent. Top assignees: Arena Pharmaceuticals, Inc., Other. Active years: 2015-2020.
Company Filing History:
3 out of 218 
1 out of 834,307 Years Active: 2015-2020
Title: Paul Maffuid: Innovator in Serotonin Receptor Modulation
Introduction
Paul Maffuid is a notable inventor based in Carlsbad, CA (US). He has made significant contributions to the field of pharmacology, particularly in the development of serotonin receptor modulators. With a total of 4 patents to his name, Maffuid's work focuses on addressing various sleep and psychological disorders.
Latest Patents
Maffuid's latest patent involves a composition of a 5-HT2A serotonin receptor modulator. This invention is particularly useful for treating disorders related to sleep, such as insomnia, dyssomnias, and nonrestorative sleep. The compositions are designed to enhance slow wave sleep, improve sleep consolidation, and maintain sleep quality. Additionally, they have applications in treating a range of medical conditions, including coronary artery disease, myocardial infarction, and various psychotic disorders.
Career Highlights
Throughout his career, Paul Maffuid has worked with prominent companies, including Arena Pharmaceuticals, Inc. His innovative approaches have led to advancements in therapeutic solutions for complex health issues.
Collaborations
Maffuid has collaborated with notable professionals in his field, including Lee Alani Selvey and Deam Windate Given, III. These partnerships have contributed to the development and refinement of his inventions.
Conclusion
Paul Maffuid's contributions to the field of serotonin receptor modulation highlight his commitment to improving health outcomes. His innovative patents continue to pave the way for advancements in the treatment of sleep and psychological disorders.